Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 85

Cited In for PubMed (Select 10379017)

1.

Cost-effectiveness analysis of three different combinations of inhalers for severe and very severe chronic obstructive pulmonary disease patients at a tertiary care teaching hospital of South India.

Altaf M, Zubedi AM, Nazneen F, Kareemulla S, Ali SA, Aleemuddin NM, Hannan Hazari MA.

Perspect Clin Res. 2015 Jul-Sep;6(3):150-158.

PMID:
26229751
2.

LAMA/LABA vs ICS/LABA in the treatment of COPD in Japan based on the disease phenotypes.

Hizawa N.

Int J Chron Obstruct Pulmon Dis. 2015 Jun 10;10:1093-102. doi: 10.2147/COPD.S72858. eCollection 2015. Review.

3.

Prognostic factors for clinical failure of exacerbations in elderly outpatients with moderate-to-severe COPD.

Wilson R, Anzueto A, Miravitlles M, Arvis P, Haverstock D, Trajanovic M, Sethi S.

Int J Chron Obstruct Pulmon Dis. 2015 Jun 2;10:985-93. doi: 10.2147/COPD.S80926. eCollection 2015.

4.

A bibliometric analysis of the 100 most influential papers on COPD.

Gu W, Yuan Y, Yang H, Qi G, Jin X, Yan J.

Int J Chron Obstruct Pulmon Dis. 2015 Mar 25;10:667-76. doi: 10.2147/COPD.S74911. eCollection 2015.

5.

Effect of low-dose glucocorticoid on corticosteroid insufficient patients with acute exacerbation of chronic obstructive pulmonary disease.

Sun WP, Yuan GX, Hu YJ, Liao LZ, Fu L.

World J Emerg Med. 2015;6(1):34-9. doi: 10.5847/wjem.j.1920-8642.2015.01.006.

6.

Amoxicillin concentrations in relation to beta-lactamase activity in sputum during exacerbations of chronic obstructive pulmonary disease.

Brusse-Keizer M, VanderValk P, van der Zanden RW, Nijdam L, van der Palen J, Hendrix R, Movig K.

Int J Chron Obstruct Pulmon Dis. 2015 Mar 3;10:455-61. doi: 10.2147/COPD.S70355. eCollection 2015.

7.

Retrospective Assessment of Home Ventilation to Reduce Rehospitalization in Chronic Obstructive Pulmonary Disease.

Coughlin S, Liang WE, Parthasarathy S.

J Clin Sleep Med. 2015 Jun 15;11(6):663-70. doi: 10.5664/jcsm.4780.

PMID:
25766720
8.

Home-based telehealth hospitalization for exacerbation of chronic obstructive pulmonary disease: findings from "the virtual hospital" trial.

Jakobsen AS, Laursen LC, Rydahl-Hansen S, Ƙstergaard B, Gerds TA, Emme C, Schou L, Phanareth K.

Telemed J E Health. 2015 May;21(5):364-73. doi: 10.1089/tmj.2014.0098. Epub 2015 Feb 5.

PMID:
25654366
9.
10.

Systemic corticosteroids in acute exacerbation of COPD: a meta-analysis of controlled studies with emphasis on ICU patients.

Abroug F, Ouanes I, Abroug S, Dachraoui F, Abdallah SB, Hammouda Z, Ouanes-Besbes L.

Ann Intensive Care. 2014 Oct 26;4:32. doi: 10.1186/s13613-014-0032-x. eCollection 2014. Review.

11.

Necessity of amoxicillin clavulanic acid in addition to prednisolone in mild-to-moderate COPD exacerbations.

Brusse-Keizer M, VanderValk P, Hendrix R, Kerstjens H, van der Palen J.

BMJ Open Respir Res. 2014 Dec 30;1(1):e000052. doi: 10.1136/bmjresp-2014-000052. eCollection 2014.

12.

Chronic obstructive pulmonary disease: respiratory review of 2014.

Lee YM.

Tuberc Respir Dis (Seoul). 2014 Oct;77(4):155-60. doi: 10.4046/trd.2014.77.4.155. Epub 2014 Oct 31. Review.

13.
14.

Prevention of acute exacerbations of COPD: American College of Chest Physicians and Canadian Thoracic Society Guideline.

Criner GJ, Bourbeau J, Diekemper RL, Ouellette DR, Goodridge D, Hernandez P, Curren K, Balter MS, Bhutani M, Camp PG, Celli BR, Dechman G, Dransfield MT, Fiel SB, Foreman MG, Hanania NA, Ireland BK, Marchetti N, Marciniuk DD, Mularski RA, Ornelas J, Road JD, Stickland MK.

Chest. 2015 Apr;147(4):894-942. doi: 10.1378/chest.14-1676. Review.

PMID:
25321320
15.

Chronic obstructive pulmonary disease exacerbations: latest evidence and clinical implications.

Qureshi H, Sharafkhaneh A, Hanania NA.

Ther Adv Chronic Dis. 2014 Sep;5(5):212-27. doi: 10.1177/2040622314532862. Review.

16.

Gaining the Upper Hand on Pulmonary Drug Delivery.

Tyrrell J, Tarran R.

J Pharmacovigil. 2014 Mar 1;2(1):118.

17.

Impact of an educational intervention on steroid prescribing and dosing effect on patient outcomes in COPD exacerbations.

Hope NH, Ray SM, Franks AS, Heidel E.

Pharm Pract (Granada). 2010 Jul;8(3):162-6. Epub 2010 Mar 15.

18.

Corticosteroids in the treatment of acute exacerbations of chronic obstructive pulmonary disease.

Woods JA, Wheeler JS, Finch CK, Pinner NA.

Int J Chron Obstruct Pulmon Dis. 2014 May 3;9:421-30. doi: 10.2147/COPD.S51012. eCollection 2014. Review.

19.

The Saudi Guidelines for the Diagnosis and Management of COPD.

Khan JH, Lababidi HM, Al-Moamary MS, Zeitouni MO, Al-Jahdali HH, Al-Amoudi OS, Wali SO, Idrees MM, Al-Shimemri AA, Al Ghobain MO, Alorainy HS, Al-Hajjaj MS.

Ann Thorac Med. 2014 Apr;9(2):55-76. doi: 10.4103/1817-1737.128843.

20.

Predictors of early readmission among patients 40 to 64 years of age hospitalized for chronic obstructive pulmonary disease.

Sharif R, Parekh TM, Pierson KS, Kuo YF, Sharma G.

Ann Am Thorac Soc. 2014 Jun;11(5):685-94. doi: 10.1513/AnnalsATS.201310-358OC.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk